z-logo
open-access-imgOpen Access
A paradigm linking herpesvirus immediate-early gene expression apoptosis and myalgic encephalomyelitis chronic fatigue syndrome
Author(s) -
Martin Lerner,
Lerner
Publication year - 2011
Publication title -
virus adaptation and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.459
H-Index - 9
ISSN - 1179-1624
DOI - 10.2147/vaat.s15105
Subject(s) - human herpesvirus 6 , lytic cycle , virology , chronic fatigue syndrome , virus , epstein–barr virus , human cytomegalovirus , cytomegalovirus , immediate early gene , biology , immunology , herpesviridae , gammaherpesvirinae , medicine , gene , gene expression , viral disease , genetics
correspondence: A Martin Lerner 32804 Pierce rd, Beverly hills, Mi 48025, UsA Tel +1 248 540 9866 Fax +1 248 540 0139 email amartinlerner@yahoo.com Abstract: There is no accepted science to relate herpesviruses (Epstein–Barr virus [EBV], human cytomegalovirus [HCMV], and human herpesvirus 6 [HHV6]) as causes of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). ME/CFS patients have elevated serum immunoglobulin (Ig)G serum antibody titers to EBV, HCMV, and HHV6, but there is no herpesvirus DNA-emia, herpesvirus antigenemia, or uniformly elevated IgM serum antibody titers to the complete virions. We propose that herpesvirus EBV, HCMV, and HHV6 immediate-early gene expression in ME/CFS patients leads to host cell dysregulation and host cell apoptosis without lytic herpesvirus replication. Specific antiviral nucleosides, which alleviate ME/CFS, namely valacyclovir for EBV ME/CFS and valganciclovir for HCMV/ HHV6 ME/CFS, inhibit herpesvirus DNA polymerases and/or thymidine kinase functions, thus inhibiting lytic virus replication. New host cell recruitment thus ceases. In the absence of new herpesvirus, nonpermissive herpesvirus replication stops, and ME/CFS recovery ensues.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom